poisar

Stocks · News reference

Kiniksa Pharmaceuticals Raises FY2026 Sales Guidance from $930.000M-$945.000M to $980.000M-$995.000M vs $940.106M Est

Jul 28, 2026, 11:30 AMBenzinga Newsdesk

Kiniksa Pharmaceuticals (NASDAQ:KNSA) raises FY2026 sales outlook from $930.000 million-$945.000 million to $980.000 million-$995.000 million vs $940.106 million estimate.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

KNSA
Source
benzinga
Observed
Jul 28, 2026, 11:30 AM
Checked
Jul 28, 2026, 11:30 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading